John Simmons
Global Vice President - Biopharma & Oncology Partnerships Natera
Seminars
Tuesday 6th October 2026
What Becomes Possible Combing MRD, Multi-Omics & RWD Insights
8:35 am
- Explore how combining MRD with multi-omics and real-world data can provide a more complete view of disease biology, treatment response and patient outcomes
- Examine how integrated longitudinal insights can support earlier development decisions, more efficient clinical trials, and the advancement of ctDNA-based endpoints
- Consider what becomes possible for oncology drug development as these data sources converge from improved patient selection and trial design to faster evidence generation and more personalized treatment strategies
